Atlanta, GA - August 3, 2007
Grand Hyatt Atlanta
3300 Peachtree Road, NE
Atlanta, GA 30305
404-365-8100
8:15 AM - 4:00 PM
11.5 AAFP Prescribed Credits Approved
Up to 6.5 AMA PRA Category 1 Credits™
The American Academy of Family Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ACCME: The American Academy of Family Physicians designates this education activity for a maximum of 6.5 AMA PRA Category 1 Credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
AAFP: This activity has been reviewed and is acceptable for up to 11.5 Prescribed credits by the American Academy of Family Physicians. Of these credits, 5.0 conform to the AAFP criteria for evidence-based CME clinical content. CME credit has been increased to reflect 2 for 1 credit for only the EB CME portion. When reporting AAFP credit, claim total Prescribed and Elective credit for this activity. It is not necessary to label credit as evidence-based CME for reporting purposes.
AOA: This program has been accredited by the American Osteopathic Association for 6.5 credit hours of AOA Category 2-A credit.
AAPA: AAPA accepts Prescribed credit from the AAFP.
AANP: This program has been approved for up to 6.5 contact hours of continuing education (which includes up to 3.0 hours of pharmacology) by the American Academy of Nurse Practitioners. Program ID 0707317
Benign Prostatic Hypertrophy
- Accurately diagnose BPH on the basis of presenting symptoms and a careful physical;
- Rule out other causes of lower urinary tract symptoms (to include urinary tract and prostatic infections, medication side effects, overactive bladder, and prostate cancer); and
- Identify appropriate treatment matched to the patient's situation, including any comorbidities, such as erectile dysfunction and blood pressure problems.
Chronic Constipation in Adults
- Discuss the etiologies of chronic constipation;
- Identify treatment options for chronic constipation;
- Explain the importance and details of behavioral therapy for chronic constipation; and
- Describe treatment options for constipation-predominant irritable bowel syndrome.
Diabetes
- Describe the diagnostic criteria for type 2 diabetes;
- Recognize risk factors for type 2 diabetes and understand a range of tactics for helping patients minimize those that are modifiable;
- Implement recommended methods for early detection of complications of type 2 diabetes in practice;
- Understand the place of newer agents for managing diabetes in the context of more familiar agents.
- Gain appreciation of the support AAFP and its publications provide in the area of diabetes.
Hyperlipidemia
- Describe how primary care physicians are performing in management of hyperlipidemia;
- Rapidly assess risk stratification for coronary heart disease and its implications for lipid management;
- Apply the NCEP guidelines in practice while understanding their limitations;
- Help patients develop a “therapeutic lifestyle change”;
- Provide evidence-based interventions to optimize lipid levels using diet and drugs;
- Implement systems to enhance effectiveness of managing patients with hyperlipidemia in practice; and
- Gain appreciation of the support AAFP and its publications provide in the area of hyperlipidemia.
Immunizations in Adolescents
- Understand recent changes in immunization guidelines (Tdap, MCV4, etc);
- Identify contraindications to immunizations in adolescent patients;
- Specify an appropriate catch-up schedule for the adolescent who is behind in immunizations;
- Understand the rationale for the ACS and ACIP guidelines on HPV immunization and the arguments for and against widespread HPV immunization; and
- Identify significant barriers to immunization among adolescents and design an effective approach for increasing adolescent immunization rates in practice.
Insomnia
- Discuss the etiologies of insomnia;
- Explain the importance and details of behavioral therapy (sleep hygiene) for insomnia; help patients understand the respective roles of behavioral and pharmacologic therapy for insomnia;
- Understand the limitations and adverse effects of pharmacologic therapy and the inappropriateness, in most cases, of long-term pharmacologic therapy; and
- Prescribe appropriate interventions, both behavioral and pharmacologic.
Program Chair:
Kenny Lin, MD, FAAFP - Assistant Professor of Clinical Family Medicine, Georgetown University School of Medicine, Washington, DC; Assistant Editor, American Family Physician, American Academy of Family Physicians, Leawood, KS
Moderator:
Louis Kuritzsky, MD - Clinical Assistant Professor, Department of Community Health and Family Medicine, University of Florida, Gainesville, FL
Presenting Faculty:
B. Wayne Blount, MD – Professor and Executive Vice Chair, Department of Family and Preventive Medicine; Program Director, Preventive Medicine Residency, Emory University School of Medicine, Atlanta, GA; Chief of Service, Family Medicine Emory Dunwoody Medical Center, Atlanta, GA
Thomas Irons, MD – Associate Vice Chancellor for Health Sciences and Professor of Pediatrics, The Brody School of Medicine, East Carolina University, Greenville, NC
Louis Kuritzsky, MD - Clinical Assistant Professor, Department of Community Health and Family Medicine, University of Florida, Gainesville, FL
Donald B. Middleton, MD – Professor, Family Medicine; Vice President of Family Practice Education, University of Pittsburgh Medical Center, Pittsburgh, PA
Brian V. Reamy , MD – Associate Professor & Chair, Department of Family Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD
7:45 a.m. Registration and Breakfast
8:15 a.m. Welcome and Overview
8:30 a.m. BPH
Dr. B. Wayne Blount
9:30 a.m. Adolescent Immunizations
Dr. Thomas Irons
10:30 a.m. Refreshment Break / Exhibits
10:45 a.m. Diabetes
Dr. B. Wayne Blount
11:45 p.m. Questions and Answers (Topics 1- 3)
12:00 p.m. Box Lunch / Exhibits
12:30 p.m. Chronic Constipation
Dr. Louis Kuritzsky
1:30 p.m. Insomnia
Dr. Donald Middleton
2:30 p.m. Refreshment Break / Exhibits
2:45 p.m. Hyperlipidemia
Dr. Brian V. Reamy
3:45 p.m. Questions and Answers (Topics 4 - 6)
Supported by educational grants from the following companies:
Boehringer Ingelheim Pharmaceuticals, Inc.;
Merck & Co., Inc.; Merck/Schering Plough Pharmaceuticals
sanofi aventis, U.S. Inc.; Sucampo Pharmaceuticals, Inc. &
Takeda Pharmaceuticals North America, Inc.
